Physician profile
Ronald Leon Gross
NPI 1902890544
$142,874.17
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $30K · 2021: $21K · 2022: $150 · 2023: $276 · 2024: $443 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $88,271.32 | 2019-2021 | |
| Allergan, INC. | $46,717.79 | 2019-2020 | |
| Glaukos Corporation | $6,733.51 | 2020-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $295.86 | 2024-2025 | Clareon, Hydrus Microstent |
| New World Medical,INC. | $276.27 | 2023 | |
| Abbvie INC. | $156.06 | 2024 | |
| Cvrx, INC. | $150.00 | 2022 | |
| Genentech, INC. | $138.20 | 2019 | |
| Tearlab Corp | $95.87 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $20.58 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.71 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.